Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Takamura

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|November 11, 2021
Hemodynamic Stratification of the Pulmonary Vasculature in Patients Undergoing Transcatheter Aortic Valve ReplacementKenji Sakata, Masayuki Takamura
Internal Medicine (Tokyo, Japan)|August 27, 2025
Oral Semaglutide Further Reduced LDL Cholesterol in a Patient with Familial Hypercholesterolemia Treated with Statins, Ezetimibe, and EvolocumabHayato Tada, Masayuki Takamura
Circulation Journal : Official Journal of the Japanese Circulation Society|May 31, 2019
Insights From 10-Year Outcomes of Mesenchymal Stem Cell Transplantation in Heart Failure PatientsOto Inoue, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|July 27, 2022
Finding Clues to Protect Against Coronary Atherosclerosis via Traditional Risk FactorsHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|March 29, 2026
An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering TherapyHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|May 10, 2026
It's Time to Measure Lp(a): Recognizing a Neglected Cardiovascular RiskHayato Tada, Masayuki Takamura
Atherosclerosis|June 29, 2024
Toward personalized medicine in patients with familial hypercholesterolemiaHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|February 18, 2024
Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 15, 2024
A fascinating association between HDL as a multi-potent particle and hypertensionHayato Tada, Masayuki Takamura
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2026
Unanswered Questions About the Relationship Between Lipoprotein(a) and Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Circulation Journal : Official Journal of the Japanese Circulation Society|November 11, 2021
Hemodynamic Stratification of the Pulmonary Vasculature in Patients Undergoing Transcatheter Aortic Valve ReplacementKenji Sakata, Masayuki Takamura
Internal Medicine (Tokyo, Japan)|August 27, 2025
Oral Semaglutide Further Reduced LDL Cholesterol in a Patient with Familial Hypercholesterolemia Treated with Statins, Ezetimibe, and EvolocumabHayato Tada, Masayuki Takamura
Circulation Journal : Official Journal of the Japanese Circulation Society|May 31, 2019
Insights From 10-Year Outcomes of Mesenchymal Stem Cell Transplantation in Heart Failure PatientsOto Inoue, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|July 27, 2022
Finding Clues to Protect Against Coronary Atherosclerosis via Traditional Risk FactorsHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|March 29, 2026
An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering TherapyHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|May 10, 2026
It's Time to Measure Lp(a): Recognizing a Neglected Cardiovascular RiskHayato Tada, Masayuki Takamura
Atherosclerosis|June 29, 2024
Toward personalized medicine in patients with familial hypercholesterolemiaHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|February 18, 2024
Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 15, 2024
A fascinating association between HDL as a multi-potent particle and hypertensionHayato Tada, Masayuki Takamura
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2026
Unanswered Questions About the Relationship Between Lipoprotein(a) and Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Pageof 27